MSOS holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 73.78% at a quoted market price (level 1), 3 issuer countries.

MSOS's largest investment is Curaleaf Holdings Inc SUB VTG at 12.32% of net assets. Trulieve Cannabis Corp SUB VTG and Blackrock Treasury Trust follow; the three together are 27.66%. Between the 2026-03-31 and 2026-06-30 filings 4 positions were added and 5 dropped; 68.3% of the weight moved. Canada is the largest country at 60.29% of the portfolio, across 3 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

The 13 largest of 40 positions in MSOS's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Lines the filer classes as derivatives are included at their filed value, which is not their exposure; a swap or option line may carry a counterparty's name. The exposure itself is in the section on counterparties below. Every position, every quarter: MSOS.csv.gz.

Share of MSOS's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of MSOS's own filings, 70 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference — percentage points over 0 months, which is roughly the distributions. Every month with the filing it came from: MSOS.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-06-30, $1,000 was out to 1 borrower, 0.00% of net assets.

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter MSOS has filed, with each borrower: MSOS.json · all funds.

16 positions became 15: 4 added (37.1% of the fund at the later date), 5 dropped (40.9% at the earlier date). Half the sum of all weight changes, a turnover proxy: 68.3%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of MSOS compared this way, as a feed: changes.xml · all funds: filings received.

New: CURALEAF HOLDINGS INC (33.88%), MORGAN STANLEY & CO. LLC (3.14%), CANTOR FITZGERALD & CO. (0.03%), NOMURA INTERNATIONAL PLC (0.01%). Gone: Curaleaf Holdings Inc (35.60%), NOMURA INTERNATIONAL PLC (3.46%), SNDL Inc (1.76%), NOMURA INTERNATIONAL PLC (0.05%), COWEN INC. (0.01%).

73.8% of MSOS is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $1.05B. Notional of an interest-rate or currency swap is not equity exposure.

Financing leg as filed: the fund pays CRESCO LABS INC + 0% on $295M of long swap notional . Issuers fill the spread field differently (some file the all-in rate), so compare within an issuer, not across.

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of MSOS (6.2). Same filings, same arithmetic. Position in this list says nothing about which fund is better.